scispace - formally typeset
F

Francesco Auriemma

Researcher at University of Naples Federico II

Publications -  66
Citations -  574

Francesco Auriemma is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 27 publications receiving 333 citations.

Papers
More filters
Journal ArticleDOI

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

Paolo Caraceni, +92 more
- 16 Jun 2018 - 
TL;DR: Long-term HA administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis in this trial.
Journal ArticleDOI

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

TL;DR: Patients with chronic hepatitis C and SVR show an excellent prognosis with no risk of recurrence and a very low rate of mortality, and data indicate that virus-eradication following interferon treatment can last up to 20 years.
Journal ArticleDOI

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

Paolo Caraceni, +92 more
TL;DR: Baseline serum albumin per se should not guide the decision to start albumin therapy and could be used as a guide in order to improve the use of albumin, 4.0 g/dL being the target threshold to be pursued.
Journal ArticleDOI

Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.

TL;DR: It seems clear that it is desirable to concentrate efforts on prospective studies, not conducting further reviews of the literature in the continued absence of new evidence on the risk of viral hepatitis reactivation in patients with inflammatory bowel disease who are treated with immunosuppressive drugs.
Journal ArticleDOI

Radiofrequency and malignant biliary strictures: An update

TL;DR: Focus on technical success defined as deployment of the RF catheter, virtually succeeded in all patients included in the studies are addressed, and current impression is limited.